查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1574302

帕金森氏症的深部脑部刺激治疗市场：按产品、最终用户划分 - 全球预测 2025-2030

Deep Brain Stimulation in Parkinson's Disease Market by Product (Dual Channel, Single Channel), End-User (Ambulatory Surgical Centers, Hospitals, Neurology Clinics) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

帕金森氏症脑深部电刺激治疗市场2023年估值为10.7亿美元，预计2024年将达12.3亿美元，复合年增长率为15.40%，2030年将达29亿美元，预计将达30美元百万。

深部脑部刺激 (DBS) 是一种在大脑特定区域植入电极的医疗程序，主要用于治疗帕金森氏症 (PD) 的运动症状，例如震颤、僵硬和运动障碍。 DBS 的需求源自于药物治疗的局限性，尤其是 PD 的晚期，此时药物治疗的效果会变得较差。 DBS 的主要用途是医院和专科诊所的神经内科和神经外科。最终用途范围延伸至传统治疗效果不够有效且寻求改善生活品质的患者。市场成长的主要驱动力是由于人口老化和神经技术的进步简化了手术程序并增强了设备功能而导致帕金森氏症的盛行率不断增加。关键的成长要素包括持续的技术创新，例如与 MRI 相容的 DBS 系统，以及由于积极的长期安全性和有效性资料而不断提高的接受度。潜在的机会存在于扩展到新兴市场，在这些市场中，DBS 的渗透率仍然较低，但 PD 盛行率正在上升，以及开发下一代技术，例如提供即时调整的闭合迴路系统。对公司的建议包括投资研发创新，使设备小型化并延长电池寿命，从而提高患者的舒适度和依从性。然而，由于 DBS 治疗成本高、认知度低以及需要高技能的手术团队，市场成长受到限制。此外，关于患者选择标准和道德问题的持续争论正在挑战市场。为了利用成长机会，公司应透过探索与医疗机构和保险公司的合作伙伴关係来重点解决成本和可近性问题。创新包括透过整合DBS和数位健康平台进行远端监控，开闢新的领域，使DBS的应用和收益多样化，并探索PD以外的领域的应用，例如精神疾病。

主要市场统计
基准年[2023] 10.7亿美元
预测年份 [2024] 12.3亿美元
预测年份 [2030] 29.3亿美元
复合年增长率（%） 15.40%

市场动态：针对帕金森氏症快速发展的深部脑部刺激治疗市场揭示的关键市场洞察

供需的动态交互作用正在改变帕金森氏症的深部脑部刺激市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 神经系统疾病增加
    • 由于人口迅速老化，神经系统疾病的风险和盛行率增加
    • 微创手术日益普及
  • 市场限制因素
    • 复杂的法律规范
  • 市场机会
    • 装备技术进步加大
    • 神经学研究和开发迅速增加
  • 市场挑战
    • 深部脑部刺激手术的併发症

波特五力：开拓帕金森氏症脑深部刺激治疗市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解帕金森氏症市场中脑深部刺激疗法的外部影响

外部宏观环境因素在塑造帕金森氏症市场脑深部刺激疗法的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解巴金森氏症脑深部刺激治疗市场的竞争格局

对帕金森氏症市场中的深部脑部刺激疗法的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

帕金森氏症市场脑深部刺激疗法供应商的 FPNV 定位矩阵绩效评估

FPNV 定位矩阵是评估帕金森氏症市场脑深部刺激疗法供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议，为帕金森氏症市场的深部脑部刺激疗法制定成功之路

对帕金森氏症市场中的深部脑部刺激疗法的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 神经系统疾病发生率增加
      • 人口迅速老化，神经系统疾病的风险和盛行率增加
      • 微创手术日益普及
    • 抑制因素
      • 复杂的法规结构
    • 机会
      • 加速设备技术进步
      • 神经病学研究和开发迅速增长
    • 任务
      • 深部脑部刺激手术的併发症
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章帕金森氏症的深部脑部刺激治疗市场：副产品

  • 双通道
  • 单通道

第七章帕金森氏症的深部脑部刺激治疗市场：按最终用户

  • 门诊手术中心
  • 医院
  • 神经科门诊
  • 研究中心

第八章北美和南美帕金森氏症脑深部电刺激治疗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区巴金森氏症脑深部电刺激治疗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第10章：欧洲、中东和非洲巴金森氏症脑深部刺激治疗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议
Product Code: MRR-A339DAEFA88E

The Deep Brain Stimulation in Parkinson's Disease Market was valued at USD 1.07 billion in 2023, expected to reach USD 1.23 billion in 2024, and is projected to grow at a CAGR of 15.40%, to USD 2.93 billion by 2030.

Deep brain stimulation (DBS) is a medical procedure that involves implanting electrodes within specific brain areas; it is primarily used to manage the motor symptoms of Parkinson's Disease (PD), such as tremors, rigidity, and dyskinesia. The necessity of DBS arises from the limitations of pharmacologic treatments, particularly in advanced PD stages where medication efficacy wanes. Its primary applications span neurology and neurosurgery departments in hospitals and specialized clinics. The end-use scope extends to patients who do not respond adequately to conventional treatments and seek improved quality of life. Market growth is largely driven by the increasing prevalence of PD due to an aging population and advancements in neurotechnology that have streamlined surgical procedures and enhanced device capabilities. Key growth factors include continuous technological innovation, such as MRI-compatible DBS systems, and increasing acceptance owing to positive long-term data on safety and efficacy. Potential opportunities lie in expanding into emerging markets where DBS adoption remains low but PD prevalence is rising, and in developing next-generation technologies like closed-loop systems that offer real-time adjustments. Recommendations for businesses would include investing in R&D to innovate on device miniaturization and battery life extension, thus enhancing patient comfort and compliance. However, market growth faces limitations such as the high cost of DBS procedures, lack of awareness, and the need for highly skilled surgical teams, which may hinder implementation in resource-constrained settings. Additionally, the market is challenged by ongoing debates on patient selection criteria and ethical concerns. To leverage growth opportunities, companies should focus on addressing cost and accessibility issues by exploring partnerships with healthcare institutions and insurance providers. The best areas for innovation include the integration of DBS with digital health platforms for remote monitoring and exploring non-PD applications such as psychiatric disorders, opening new frontiers for DBS application and revenue diversification.

KEY MARKET STATISTICS
Base Year [2023] USD 1.07 billion
Estimated Year [2024] USD 1.23 billion
Forecast Year [2030] USD 2.93 billion
CAGR (%) 15.40%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Deep Brain Stimulation in Parkinson's Disease Market

The Deep Brain Stimulation in Parkinson's Disease Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidences of neurological diseases
    • Rapidly aging population, leading to risk and high prevalence of neurological disorders
    • Rising popularity of minimally invasive procedures
  • Market Restraints
    • Complex regulatory framework
  • Market Opportunities
    • Increasing technological advancement in devices
    • Surge in neurological R&D
  • Market Challenges
    • Complications of deep brain stimulation surgery

Porter's Five Forces: A Strategic Tool for Navigating the Deep Brain Stimulation in Parkinson's Disease Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Deep Brain Stimulation in Parkinson's Disease Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Deep Brain Stimulation in Parkinson's Disease Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Deep Brain Stimulation in Parkinson's Disease Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Deep Brain Stimulation in Parkinson's Disease Market

A detailed market share analysis in the Deep Brain Stimulation in Parkinson's Disease Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Deep Brain Stimulation in Parkinson's Disease Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Deep Brain Stimulation in Parkinson's Disease Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Deep Brain Stimulation in Parkinson's Disease Market

A strategic analysis of the Deep Brain Stimulation in Parkinson's Disease Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Deep Brain Stimulation in Parkinson's Disease Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Aleva Neurotherapeutics SA, Beijing Pins Medical Co.,Ltd., Boston Scientific Corporation, Functional Neuromodulation Ltd., General Electric Co., Medtronic PLC, MicroTransponder Inc., Neuronetics Inc., NeuroPace Inc., NeuroSigma, Inc., Nexstim Oy, Renishaw PLC, Siemens AG, St. Jude Medical, Inc., and Synapse Biomedical Inc..

Market Segmentation & Coverage

This research report categorizes the Deep Brain Stimulation in Parkinson's Disease Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Dual Channel and Single Channel.
  • Based on End-User, market is studied across Ambulatory Surgical Centers, Hospitals, Neurology Clinics, and Research Centers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidences of neurological diseases
      • 5.1.1.2. Rapidly aging population, leading to risk and high prevalence of neurological disorders
      • 5.1.1.3. Rising popularity of minimally invasive procedures
    • 5.1.2. Restraints
      • 5.1.2.1. Complex regulatory framework
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing technological advancement in devices
      • 5.1.3.2. Surge in neurological R&D
    • 5.1.4. Challenges
      • 5.1.4.1. Complications of deep brain stimulation surgery
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Deep Brain Stimulation in Parkinson's Disease Market, by Product

  • 6.1. Introduction
  • 6.2. Dual Channel
  • 6.3. Single Channel

7. Deep Brain Stimulation in Parkinson's Disease Market, by End-User

  • 7.1. Introduction
  • 7.2. Ambulatory Surgical Centers
  • 7.3. Hospitals
  • 7.4. Neurology Clinics
  • 7.5. Research Centers

8. Americas Deep Brain Stimulation in Parkinson's Disease Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Deep Brain Stimulation in Parkinson's Disease Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Deep Brain Stimulation in Parkinson's Disease Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Aleva Neurotherapeutics SA
  • 3. Beijing Pins Medical Co.,Ltd.
  • 4. Boston Scientific Corporation
  • 5. Functional Neuromodulation Ltd.
  • 6. General Electric Co.
  • 7. Medtronic PLC
  • 8. MicroTransponder Inc.
  • 9. Neuronetics Inc.
  • 10. NeuroPace Inc.
  • 11. NeuroSigma, Inc.
  • 12. Nexstim Oy
  • 13. Renishaw PLC
  • 14. Siemens AG
  • 15. St. Jude Medical, Inc.
  • 16. Synapse Biomedical Inc.

LIST OF FIGURES

  • FIGURE 1. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET RESEARCH PROCESS
  • FIGURE 2. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET DYNAMICS
  • TABLE 7. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY DUAL CHANNEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY SINGLE CHANNEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY NEUROLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY RESEARCH CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 102. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET, FPNV POSITIONING MATRIX, 2023